SCHEMBL4015663

SCHEMBL4015663

Nc1c[nH]c(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL28270914 0.81 TSHR (0.39)
SCHEMBL28222880 0.69 TSHR (0.38)
SCHEMBL22055900 0.69
SCHEMBL19007328 0.69
SCHEMBL5175439 0.69
SCHEMBL2487963 0.69
SCHEMBL28127490 0.69
SCHEMBL5172689 0.69
SCHEMBL5174484 0.69
SCHEMBL24091386 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4132652-A1 AXL INHIBITORS FOR ANTIVIRAL THERAPY BerGenBio ASA (NO) 2023-02-15 EP claimed
EP-3843850-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES Array BioPharma Inc. (US) 2021-07-07 EP claimed
WO-2021032883-A1 COMBINATION THERAPY OF A PATIENT SUBGROUP BERGENBIO ASA (NO) 2021-02-25 WO claimed
WO-2020047184-A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC. (US) 2020-03-05 WO claimed
CN-110026236-A Pd composite nano catalyst for hydrogen production by formic acid decomposition and preparation method thereof 大连理工大学 2019-07-19 CN claimed
CN-107001335-A The method for purifying axl receptor tyrosine kinase inhibitor \" R428 \ 卑尔根生物有限公司 2017-08-01 CN claimed
CN-105102449-B Antiviral compound 豪夫迈·罗氏有限公司 2017-06-13 CN claimed
EP-2074115-A1 N3-HETEROARYL SUBSTITUTED TRIAZOLES AND N5-HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2009-07-01 EP claimed
WO-2008083354-A1 N3-HETEROARYL SUBSTITUTED TRIAZOLES AND N5-HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2008-07-10 WO claimed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
EP-4314193-A1 STABLE AIGS FILMS Shoei Chemical Inc. (JP) 2024-02-07 EP disclosed
EP-4132652-A1 AXL INHIBITORS FOR ANTIVIRAL THERAPY BerGenBio ASA (NO) 2023-02-15 EP disclosed
CN-112978709-A Carbon quantum dot precursor composition, carbon quantum dot and preparation method thereof 中国科学院大连化学物理研究所 2021-06-18 CN disclosed
WO-2021032883-A1 COMBINATION THERAPY OF A PATIENT SUBGROUP BERGENBIO ASA (NO) 2021-02-25 WO disclosed
CN-107001335-B Method for purifying AXL receptor tyrosine kinase inhibitor \"R428 卑尔根生物有限公司 2020-02-07 CN disclosed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US disclosed
WO-2005074875-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-08-18 WO disclosed
EP-0614915-B1 Polymer scale preventive agent SHINETSU CHEMICAL CO (JP) 1998-06-24 EP disclosed
US-5420214-A Process to prevent scale adhesion using condensation product of a diamino heterocyclic and a quinone SHIN-ETSU CHEMICAL CO., LTD. (JP) 1995-05-30 US disclosed
EP-0614915-A1 Polymer scale preventive agent Shin-Etsu Chemical Co., Ltd. (JP) 1994-09-14 EP disclosed